Actinium Pharmaceuticals Inc (NYSE American:ATNM)

7.71
Delayed Data
As of Mar 05
 -0.22 / -2.77%
Today’s Change
4.71
Today|||52-Week Range
19.47
-1.15%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Actinium Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 65.00 and a low estimate of 25.00. The median estimate represents a +418.81% increase from the last price of 7.71.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Actinium Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.40
Sales
$0.00
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.04%
 
 
 
 
 
 
Growthannually 56.96%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.